An Open Label Comparative Clinical Study To Assess The Effect Of Dasamoolaksheeradhara As An Add On Therapy With Standard Care In Conventional Medicine In Diabetic Neuropathy

Dr Anjaly NV0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Diagnosed cases of diabetic neuropathy fulfilling the diagnostic criteria.
•Patients having hemoglobin A1c(HbA1c) >6.5% at screening.
•Patient having FBS <=200 mg/dL at screening.
•Patients currently treated with Standerd care in Modern medicine.
•Patient willing to give a signed informed consent form prior to start of the study.

•Patient has hypersensitivity to any of the study medications
•Patient is a nursing mother, Pregnant.
•Patient has used injected anesthetics or steroids within 30 days of baseline.
•Known cases of Skinleisons, malignancy,, any non-diabetic neurologic disorders, seriouds health issues
•Patient has certain conditions that could confound evaluation of DPN, in particular, amputations other than toes, (e.g. phantom limb pain), and skin conditions affecting sensation in painful limbs.
•Patient has skin conditions in the area affected by the neuropathy that could alter sensation.
•Patient is in an immunocompromised state.
•Patient has any abnormal chemistry or hematology results that are deemed by the investigator to be clinically significant.
•Patient has a history of pernicious anemia, untreated hypothyroidism, chronic hepatitis B or C, hepatitis within the past 3 months, or HIV infection.
•Patient has any other serious medical condition.

发起方

Dr Anjaly NV